Tag: Acquisition

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...

Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with ...

Sanofi is boosting its vaccine portfolio and pipeline through the acquisition of Dynavax Technologies, a $2.2 billion deal bringing assets ...

Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus ...

Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup ...

Pfizer’s internal obesity drug R&D stumbled, but the pharmaceutical giant is leaping ahead in this field through the multi-billion dollar ...

After a multi-year battle, the $3.3 billion acquisition of home health provider Amedisys by UnitedHealth Group’s Optum may finally go ...

Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a ...

The world’s tech giants continue to go after strategic acquisitions aimed at deepening their presence in the healthcare world. On ...

Healthcare company Astrana Health has finalized the acquisition of Prospect Health, an integrated care delivery network, for $708 million, lower ...